{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T10:05:46Z","timestamp":1779444346449,"version":"3.53.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00467-025-07115-3","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T08:46:39Z","timestamp":1765874799000},"page":"1909-1912","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimal selection and timing of steroid-sparing therapy in childhood nephrotic syndrome: what determines long-term outcomes of adult survivors?"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2957-3705","authenticated-orcid":false,"given":"Shuichiro","family":"Fujinaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Miyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Sakuraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amane","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Ohtomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"7115_CR1","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1007\/s00467-025-06811-4","volume":"40","author":"MR Denburg","year":"2025","unstructured":"Denburg MR, Hirabayashi K, Davies AG, Razzaghi H, Dharnidharka VR, Dixon BP, Flynn JT, Gluck CA, Mitsnefes MM, Smoyer WE, Furth SL, Forrest CB (2025) Utilization of anti-CD20 antibodies for treatment of childhood nephrotic syndrome, 2010 to 2022. Pediatr Nephrol 40:3121\u20133127","journal-title":"Pediatr Nephrol"},{"key":"7115_CR2","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1007\/s00467-025-06853-8","volume":"40","author":"A Aguilar-Gonz\u00e1lez","year":"2025","unstructured":"Aguilar-Gonz\u00e1lez A, Zardynezhad A, Morgan C, Dart A, Mammen C, Parekh RS, Geier P, Benoit G, Filler G, Feber J, Tee J, Arora S, Noone D, Grisaru S, Chanchlani R, Okpere A, Samuel S (2025) Practice variation in the use of steroid-sparing therapies in childhood steroid-sensitive nephrotic syndrome: results from a prospective cohort study. Pediatr Nephrol 40:3437\u20133445","journal-title":"Pediatr Nephrol"},{"key":"7115_CR3","doi-asserted-by":"crossref","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Nephrotic Syndrome In Children Work Group, Floege J, Gibson KL, Vivarelli M, Liew A, Radhakrishnan J, Rovin BH (2025) KDIGO 2025 clinical practice guideline for the management of nephrotic syndrome in children. Kidney Int 107:S241\u2013S289","DOI":"10.1016\/j.kint.2024.11.007"},{"key":"7115_CR4","doi-asserted-by":"crossref","unstructured":"Sinha A, Bagga A, Banerjee S, Mishra K, Mehta A, Agarwal I, Uthup S, Saha A, Mishra OP; Expert Group of Indian Society of Pediatric Nephrology (2021) Steroid sensitive nephrotic syndrome: revised guidelines. Indian Pediatr 58:461\u2013481","DOI":"10.1007\/s13312-021-2217-3"},{"key":"7115_CR5","doi-asserted-by":"crossref","unstructured":"Ehren R, Benz MR, Brinkk\u00f6tter PT, D\u00f6tsch J, Eberl WR, Gellermann J, Hoyer PF, Jordans I, Kamrath C, Kemper MJ, Latta K, M\u00fcller D, Oh J, T\u00f6nshoff B, Weber S, Weber LT, German Society for Pediatric Nephrology (2021) Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy -short version of the updated German best practice guideline (S2e) - AWMF register no. 166\u2013001, 6\/2020. Pediatr Nephrol 36:2971\u20132985","DOI":"10.1007\/s00467-021-05135-3"},{"key":"7115_CR6","doi-asserted-by":"crossref","unstructured":"Trautmann A, Boyer O, Hodson E, Bagga A, Gipson DS, Samuel S, Wetzels J, Alhasan K, Banerjee S, Bhimma R, Bonilla-Felix M, Cano F, Christian M, Hahn D, Kang HG, Nakanishi K, Safouh H, Trachtman H, Xu H, Cook W, Vivarelli M, Haffner D, International Pediatric Nephrology Association (2023) IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 38:877\u2013919","DOI":"10.1007\/s00467-022-05739-3"},{"key":"7115_CR7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10157-025-02636-5","volume":"29","author":"R Hamada","year":"2025","unstructured":"Hamada R, Kaku Y, Inaba A, Kaito H, Kimata T, Kondo S, Sako M, Sato M, Sugimoto K, Tanaka S, Nagaoka Y, Nozu K, Hashimoto J, Miura K, Yamamoto M, Kawai F, Maruyama S, Ishikura K (2025) A digest of the clinical practice guideline for pediatric idiopathic nephrotic syndrome 2020 updated: medical therapy. Clin Exp Nephrol 29:691\u2013701","journal-title":"Clin Exp Nephrol"},{"key":"7115_CR8","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0140-6736(85)91387-X","volume":"16","author":"RS Trompeter","year":"1985","unstructured":"Trompeter RS, Lloyd BW, Hicks J, White RH, Cameron JS (1985) Long-term outcome for children with minimal-change nephrotic syndrome. Lancet 16:368\u2013370","journal-title":"Lancet"},{"key":"7115_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0140-6736(89)91266-X","volume":"4","author":"MA Lewis","year":"1989","unstructured":"Lewis MA, Baildom EM, Davis N, Houston IB, Postlethwaite RJ (1989) Nephrotic syndrome: from toddlers to twenties. Lancet 4:255\u2013259","journal-title":"Lancet"},{"key":"7115_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1053\/ajkd.2003.50116","volume":"41","author":"F Fakhouri","year":"2003","unstructured":"Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Gr\u00fcnfeld JP, Niaudet P (2003) Steroid-sensitive nephrotic syndrome: from childhood to adulthood. Am J Kidney Dis 41:550\u2013557","journal-title":"Am J Kidney Dis"},{"key":"7115_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jpeds.2005.03.050","volume":"147","author":"EM R\u00fcth","year":"2005","unstructured":"R\u00fcth EM, Kemper MJ, Leumann EP, Laube GF, Neuhaus TJ (2005) Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr 147:202\u2013207","journal-title":"J Pediatr"},{"key":"7115_CR12","doi-asserted-by":"crossref","unstructured":"Ishikura K, Yoshikawa N, Nakazato H, Sasaki S, Nakanishi K, Matsuyama T, Ito S, Hamasaki Y, Yata N, Ando T, Iijima K, Honda M; Japanese Study Group of Renal Disease in Children (2015) Morbidity in children with frequently relapsing nephrosis: 10-year follow-up of a randomized controlled trial. Pediatr Nephrol 30:459\u2013468","DOI":"10.1007\/s00467-014-2955-8"},{"key":"7115_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00467-023-06108-4","volume":"39","author":"Y Takemasa","year":"2024","unstructured":"Takemasa Y, Fujinaga S, Nakagawa M, Sakuraya K, Hirano D (2024) Adult survivors of childhood-onset steroid-dependent and steroid-resistant nephrotic syndrome treated with cyclosporine: a long-term single-center experience. Pediatr Nephrol 39:473\u2013482","journal-title":"Pediatr Nephrol"},{"key":"7115_CR14","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s00467-019-04339-y","volume":"34","author":"S Fujinaga","year":"2019","unstructured":"Fujinaga S, Hirano D, Nishino T, Umeda C, Watanabe Y, Nakagawa M (2019) Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine. Pediatr Nephrol 34:2417\u20132421","journal-title":"Pediatr Nephrol"},{"key":"7115_CR15","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s00467-016-3400-y","volume":"31","author":"L Dehoux","year":"2016","unstructured":"Dehoux L, Hogan J, Dossier C, Fila M, Niel O, Maisin A, Macher MA, Kwon T, Baudouin V, Desch\u00eanes G (2016) Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome. Pediatr Nephrol 31:2095\u20132101","journal-title":"Pediatr Nephrol"},{"key":"7115_CR16","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1001\/jamapediatrics.2018.1323","volume":"172","author":"B Basu","year":"2018","unstructured":"Basu B, Sander A, Roy B, Preussler S, Barua S, Mahapatra TKS, Schaefer F (2018) Efficacy of rituximab vs tacrolimus in pediatric corticosteroid-dependent nephrotic syndrome: a randomized clinical trial. JAMA Pediatr 172:757\u2013764","journal-title":"JAMA Pediatr"},{"key":"7115_CR17","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00467-020-04570-y","volume":"35","author":"JA Kari","year":"2020","unstructured":"Kari JA, Alhasan KA, Albanna AS, Safdar OY, Shalaby MA, B\u00f6ckenhauer D, El-Desoky SM (2020) Rituximab versus cyclophosphamide as first steroid-sparing agent in childhood frequently relapsing and steroid-dependent nephrotic syndrome. Pediatr Nephrol 35:1445\u20131453","journal-title":"Pediatr Nephrol"},{"key":"7115_CR18","doi-asserted-by":"publisher","unstructured":"Iijima K, Sako M, Horinouchi T, Sakai T, Yamamura T, Hamada R, Ohtsuka Y, Tanaka S, Kamei K, Tanaka R, Kano Y, Kubota T, Shima Y, Morohashi T, Inaba A, Fujinaga S, Oka M, Kaito H, Konishi A, Nagano C, Nakanishi K, Ishikura K, Ito S, Nakamura H, Ghiggeri GM, Mori R, Omori T, Nozu K; Japanese Study Group of Kidney Disease in Children JSKDC10 Study (2025) Rituximab-induced long-term remission in childhood-onset, uncomplicated, frequently relapsing or steroid-dependent nephrotic syndrome: a randomized, placebo-controlled trial and a follow-up study. Sci Rep 15:34306. https:\/\/doi.org\/10.1038\/s41598-025-19214-0","DOI":"10.1038\/s41598-025-19214-0"},{"key":"7115_CR19","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00467-023-06124-4","volume":"39","author":"N Choi","year":"2024","unstructured":"Choi N, Min J, Kim JH, Kang HG, Ahn YH (2024) Efficacy and safety of long-term repeated use of rituximab in pediatric patients with nephrotic syndrome. Pediatr Nephrol 39:771\u2013780","journal-title":"Pediatr Nephrol"},{"key":"7115_CR20","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s10157-023-02374-6","volume":"27","author":"R Ohyama","year":"2023","unstructured":"Ohyama R, Fujinaga S, Sakuraya K, Hirano D, Ito S (2023) Predictive factors of long-term disease remission after rituximab administration in patients with childhood-onset complicated steroid-dependent nephrotic syndrome: a single-center retrospective study. Clin Exp Nephrol 27:865\u2013872","journal-title":"Clin Exp Nephrol"},{"key":"7115_CR21","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s10157-024-02484-9","volume":"28","author":"Y Gonda","year":"2024","unstructured":"Gonda Y, Fujinaga S (2024) Optimal course of pre-emptive rituximab administration for long-term disease remission in patients with complicated steroid-dependent nephrotic syndrome requiring immunosuppressive agents after rituximab. Clin Exp Nephrol 28:953\u2013954","journal-title":"Clin Exp Nephrol"},{"key":"7115_CR22","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s10157-024-02508-4","volume":"28","author":"E Saito","year":"2024","unstructured":"Saito E, Oura A, Kyo T, Ishigaki S, Kamei H, Nakamura Y, Soma J, Nakaya I (2024) Relapse during and after regular single-dose rituximab treatment in adult patients with steroid-dependent nephrotic syndrome. Clin Exp Nephrol 28:1082\u20131089","journal-title":"Clin Exp Nephrol"},{"key":"7115_CR23","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s00467-020-04629-w","volume":"35","author":"S Fujinaga","year":"2020","unstructured":"Fujinaga S, Nishino T, Endo S, Umeda C, Watanabe Y, Nakagawa M (2020) Unfavorable impact of anti-rituximab antibodies on clinical outcomes in children with complicated steroid-dependent nephrotic syndrome. Pediatr Nephrol 35:2003\u20132008","journal-title":"Pediatr Nephrol"},{"key":"7115_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00467-017-3866-2","volume":"33","author":"S Fujinaga","year":"2018","unstructured":"Fujinaga S, Sakuraya K (2018) Single infusion of low-dose ofatumumab in a child with complicated nephrotic syndrome with anti-rituximab antibodies. Pediatr Nephrol 33:527\u2013528","journal-title":"Pediatr Nephrol"},{"key":"7115_CR25","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1007\/s00467-025-06703-7","volume":"40","author":"S Fujinaga","year":"2025","unstructured":"Fujinaga S, Saito K, Watanabe Y, Nakagawa M, Sakuraya K (2025) Low-dose obinutuzumab for steroid-dependent nephrotic syndrome complicated by recurrent rituximab-induced serum sickness and anti-rituximab antibodies. Pediatr Nephrol 40:2493\u20132495","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-07115-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-07115-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-07115-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T09:27:11Z","timestamp":1779442031000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-07115-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["7115"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-07115-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"assertion":[{"value":"14 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study complies with the guidelines for human studies. This study does not contain any studies with animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}